Checkpoint Therapeutics (CKPT) PT Raised to $26 at H.C. Wainwright Following Positive Data
Tweet Send to a Friend
H.C. Wainwright analyst Joseph Pantginis raised the price target on Checkpoint Therapeutics (NASDAQ: CKPT) to $26.00 (from $17.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
